Dow Up 0.07% Nasdaq Up 0.61%

More On ACTC

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Ocata Therapeutics, Inc. (ACTC)

-Other OTC
6.97 Up 0.17(2.50%) Nov 13, 3:59PM EST
Prev Close:6.80
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:16.00
Beta:1.42
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:5.00 - 12.73
Volume:0
Avg Vol (3m):223,072
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ACTC

Comparison

Symbol% ChgMkt Cap
ACTCUp 2.50%N/A
GERNUp 3.62%584.82M
STEMDown 0.88%77.66M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Advanced Cell Technology, Inc., a biotechnology company, develops and commercializes human pluripotent stem cell technology in the field of regenerative medicine in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback